[WS(P)29] Cell therapy, vaccine, and new therapeutic modality

[WS29-16-P] Identification of immunogenic HLA class I and II neoantigens using surrogate immunopeptidomes

^○Serina Tokita^1,2, Takayuki Kanaseki^1,2, Toshihiko Torigoe^1,2 (1.Department of Pathology, Sapporo Medical University, 2.Joint Research Center for Immunoproteogenomics, Sapporo Medical University)

キーワード：

Neoantigen

閲覧にはパスワードが必要です

ログイン

または